John Steitz - Innophos Holdings Independent Director
Director
Mr. John M. Steitz is Independent Director of Innophos Holdings, Inc., since February 2009. He was the Chief Executive Officer of Addivant Corporationrationration, a leading global supplier of antioxidants, intermediates, inhibitors, modifiers, UV stabilizers and other additives to the plastic and rubber industries, since March 2015. Before joining Addivant, Mr. Steitz served as President and Chief Operating Officer of PQ Corporationrationration, a leading worldwide producer of specialty inorganic performance chemicals and catalysts, from October 2013. Prior to joining PQ Corporationrationration, he served as President and Chief Executive Officer of Avantor Performance Materials from August 2012 and, prior to that time, as President and Chief Operating Officer of Albemarle Corporationrationration, a leading global developer, manufacturer, and marketer of highlyengineered specialty chemicals. Before joining Albemarle, Mr. Steitz spent twenty years at Mallinckrodt, Inc., holding a variety of positions of increasing responsibility. He eventually served as vice president and general manager of Mallinckrodts pharmaceutical chemicals division. Since February 2017, Mr. Steitz has served as a director of Tredegar Corporationrationration, a publiclytraded manufacturer of plastic films and aluminum extrusions since 2009.
Age | 59 |
Tenure | 15 years |
Professional Marks | MBA |
Phone | 609 495-2495 |
Web | www.innophos.com |
John Steitz Latest Insider Activity
Tracking and analyzing the buying and selling activities of John Steitz against Innophos Holdings stock is an integral part of due diligence when investing in Innophos Holdings. John Steitz insider activity provides valuable insight into whether Innophos Holdings is net buyers or sellers over its current business cycle. Note, Innophos Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell Innophos Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
John Steitz over a month ago Acquisition by John Steitz of 8652 shares of Tredegar subject to Rule 16b-3 |
Innophos Holdings Management Efficiency
Innophos Holdings' management efficiency ratios could be used to measure how well Innophos Holdings manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 399.86 M in liabilities with Debt to Equity (D/E) ratio of 118.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Innophos Holdings has a current ratio of 2.88, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Innophos Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Innophos Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Innophos Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Innophos to invest in growth at high rates of return. When we think about Innophos Holdings' use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Horacio Scapparone | Spirit Airlines | 63 | |
Ronald Mittelstaedt | SkyWest | 54 | |
Lawrence Ellison | Tesla Inc | 73 | |
Linda Rice | Tesla Inc | 60 | |
Steve Albrecht | SkyWest | 71 | |
Carlton Donaway | Spirit Airlines | 68 | |
James Welch | SkyWest | 63 | |
Henry Meyer | United Airlines Holdings | 64 | |
Kimbal Musk | Tesla Inc | 45 | |
James Heppner | United Airlines Holdings | 60 | |
James Kennedy | United Airlines Holdings | 64 | |
Meredith Madden | SkyWest | 44 | |
Barney Harford | United Airlines Holdings | 43 | |
William Nuti | United Airlines Holdings | 53 | |
Michele Hooper | United Airlines Holdings | 66 | |
Meredith Siegfried | SkyWest | 40 | |
Edward Shapiro | United Airlines Holdings | 53 | |
Antonio Gracias | Tesla Inc | 47 | |
John Walker | United Airlines Holdings | 57 | |
Walter Isaacson | United Airlines Holdings | 65 | |
Robert Johnson | Spirit Airlines | 73 |
Management Performance
Return On Equity | 0.0014 | |||
Return On Asset | 7.0E-4 |
Innophos Holdings Leadership Team
Elected by the shareholders, the Innophos Holdings' board of directors comprises two types of representatives: Innophos Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innophos. The board's role is to monitor Innophos Holdings' management team and ensure that shareholders' interests are well served. Innophos Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innophos Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Randolph Gress, Chairman, CEO and Pres | ||
Eugenia Erlij, Vice President - Marketing | ||
Kim Mink, CEO and President and Director | ||
Abraham Shabot, Vice President Director General, Innophos Latin America | ||
James Zallie, Independent Director | ||
Peter Thomas, Director | ||
Jean Mainente, Chief Human Resource Officer, Senior Vice President | ||
William Dunworth, Chief Accounting Officer, Vice President Corporate Controller | ||
Amado Cavazos, Independent Director | ||
Nicolas Meyrial, Vice President - Commercial Nutrition | ||
William Farran, Sr. VP, General Counsel and Member of Proxy Committee | ||
Mark Thurston, Vice President - Corporate Strategy and Worldwide Business Development | ||
Mark Feuerbach, Sr. VP of Investor Relations, Treasury, Financial Planning and Analysis | ||
Mark Santangelo, Senior Vice President - Manufacturing, Engineering and EH&S | ||
Gary Cappeline, Lead Independent Director | ||
Susan Turner, Vice President - Quality & Regulatory | ||
Yasef Murat, Senior Vice President - Global Manufacturing | ||
Hermanus Kieftenbeld, CFO, Senior Vice President | ||
Linda Myrick, Independent Director | ||
Amy Hartzell, Vice President - Supply Chain and Purchasing | ||
Sherry Duff, Chief Marketing Officer, Vice President | ||
Gail Holler, Vice President - Human Resources | ||
Joshua Horenstein, Acting Chief Legal Officer and Corporate Secretary | ||
Jane Hilk, Director | ||
Louis Calvarin, Chief Risk Officer and Sr. VP of Strategy | ||
Robert Sklans, Chief Human Resource Officer, Senior Vice President | ||
Joseph Golowski, Sr. VP of Global Specialty Phosphates | ||
Charles Brodheim, Vice President Corporate Controller | ||
Karen Osar, Independent Director | ||
John Steitz, Independent Director | ||
Robert Zatta, Director |
Innophos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innophos Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0014 | |||
Return On Asset | 7.0E-4 | |||
Profit Margin | 0.0006 % | |||
Operating Margin | 14.40 % | |||
Current Valuation | 993.69 M | |||
Shares Outstanding | 19.69 M | |||
Shares Owned By Insiders | 1.36 % | |||
Shares Owned By Institutions | 98.64 % | |||
Number Of Shares Shorted | 187.27 K | |||
Price To Earning | 29.65 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Innophos Holdings information on this page should be used as a complementary analysis to other Innophos Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Innophos Stock
If you are still planning to invest in Innophos Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innophos Holdings' history and understand the potential risks before investing.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |